CirrusDx has launched LacP™, a new Lactobacillus panel aimed at enhancing vaginal health assessments. This innovative product is designed to provide healthcare professionals with critical insights into the vaginal microbiome, particularly the presence and levels of Lactobacillus species, which play a key role in maintaining vaginal health.
The LacP™ panel offers a comprehensive analysis that can assist in diagnosing conditions related to vaginal flora imbalances, such as bacterial vaginosis and yeast infections. By utilizing advanced technology, LacP™ aims to support clinicians in making informed decisions regarding treatment and management of vaginal health.
CirrusDx emphasizes the importance of understanding the vaginal microbiome for overall women’s health. The introduction of LacP™ is expected to improve patient outcomes by facilitating more personalized healthcare strategies.
Source: news.google.com